Digital gangrene in small cell lung cancer: response to aspirin treatment

Arrowsmith, J. E.; Woodhead, M. A.; Bevan, D. H.; Nanson, E. M.; Cummin, A. R.
January 1991
Thorax;Jan1991, Vol. 46 Issue 1, p63
Academic Journal
No abstract available.


Related Articles

  • Utility of cytopathology in diagnosis and molecular testing of lung cancer. Sakinah A Thiryayi // Thorax;Oct2011, Vol. 66 Issue 10, p922 

    A letter to the editor is presented in response to an article on advances in the treatment and diagnosis of non-small cell lung cancer in a previous issue.

  • Gemcitabine.  // Reactions Weekly;4/21/2007, Issue 1148, p19 

    The article presents a case study of an older man who developed digital ischemia during treatment with gemcitabine for metastatic non-small cell lung cancer. The patient developed pain with further color changes in his digits after receiving the drug. He then received peripheral vasodilators,...

  • Adjuvant Chemotherapy with Cisplatin for Lung Cancer. Zepf, Bill // American Family Physician;9/1/2004, Vol. 70 Issue 5, p978 

    Deals with the use of adjuvant chemotherapy with cisplatin for lung cancer. Standard of care in the treatment of non-small-cell lung cancer.

  • APL during Gefitinib Treatment for Non—Small-Cell Lung Cancer. Uchida, Akiko; Matsuo, Keitaro; Tanimoto, Mitsune // New England Journal of Medicine;2/24/2005, Vol. 352 Issue 8, p843 

    A letter to the editor is presented in response to the article "APL during Gefitinib Treatment for Non-Small-Cell Lung Cancer," published in a issue in 2005.

  • Authors' reply. Janssen-Heijnen, M. L. G.; Coebergh, J. W. W. // Thorax;Aug2005, Vol. 60 Issue 8, p704 

    Presents a response from the author to a letter to the editor on his article about treatment and prognosis of elderly patients with non-small cell lung cancer.

  • Involved-field radiotherapy in limited-stage small-cell lung cancer. Chien, C.-R.; Yu, C.-J. // British Journal of Cancer;7/16/2007, Vol. 97 Issue 2, p275 

    A letter to the editor is presented in response to an article regarding involved-field radiotherapy as an effective treatment for limited-stage small-cell lung cancer.

  • Cisplatin/gemcitabine.  // Reactions Weekly;1/12/2008, Issue 1184, p14 

    The article describes the case of a 46-year old woman who developed renal infarction during treatment with cisplatin and gemcitabine for non-small-cell lung cancer. Results were obtained from a CT scan and analyses of her kidneys. The woman's condition improved after undergoing aspirin and ACE...

  • Chasing Mutations in the Epidermal Growth Factor in Lung Cancer. Dowell, Jonathan E.; Minna, John D. // New England Journal of Medicine;2/24/2005, Vol. 352 Issue 8, p830 

    Discusses the treatment of non-small-cell lung cancer. Incidence of non-small-cell lung cancer in the U.S.; Details of research on several treatments for non-small-cell lung cancer; Research into the development of mutations in the pathogenesis of lung cancer.

  • Regular aspirin use and lung cancer risk. Moysich, Kirsten B.; Menezes, Ravi J.; Ronsani, Adrienne; Swede, Helen; Reid, Mary E.; Cummings, K. Michael; Falkner, Karen L.; Loewen, Gregory M.; Bepler, Gerold // BMC Cancer;2002, Vol. 2, p31 

    Background: Although a large number of epidemiological studies have examined the role of aspirin in the chemoprevention of colon cancer and other solid tumors, there is a limited body of research focusing on the association between aspirin and lung cancer risk. Methods: We conducted a...

  • Aspirin reduces lung cancer threat. Hartley, Jo // GP: General Practitioner;7/8/2002, p41 

    Examines the possible reduction in the risk of lung cancer through the drug aspirin. Suppression of the inflammatory response by aspirin; Effectiveness of aspirin in reducing the risk of lung cancer in smokers; Dosage of the drug.


Read the Article


Sign out of this library

Other Topics